Migraine is a highly disabling neurological disorder that directly affects more than 1 billion
individuals worldwide. Available treatment options differ between countries and include acute, …

Migraine is one of the most prevalent and disabling diseases worldwide, but until recently,
few migraine-specific therapies had been developed. Extensive basic and clinical scientific …

We found voltage‐gated potassium channel (VGKC) antibodies in 4 of 15 patients with
limbic encephalitis (LE). Two patients with idiopathic LE had high VGKC antibody levels (>800pM…

La migraña crónica (sufrir una migraña durante 15 o más días al mes) es una enfermedad
que afecta aproximadamenteal 0, 5-2, 5% de la población según las estadísticas que se …

The transient receptor potential (TRP) superfamily of non‐selective cationic channels are
involved in several processes plausibly relevant to migraine pathophysiology, including …

INTRODUCTION Brain disorders may exhibit shared symptoms and substantial epidemiological
comorbidity, inciting debate about their etiologic overlap. However, detailed study of …

Migraine is a neurovascular disorder that affects over 1 billion people worldwide. Its widespread
prevalence, and associated disability, have a range of negative and substantial effects …

Objective To define headache characteristics and evolution in relation to COVID-19 and its
inflammatory response. Methods This is a prospective study, comparing clinical data and …

Encephalopathy associated with autoimmune thyroid disease is an underdiagnosed clinical
condition. No specific disease marker exists and to date, imaging techniques have not …

Introducción En el campo de las cefaleas, onabotulinumtoxinA (onabotA) tiene indicación
bien establecida en la migraña crónica (MC). Además, en los últimos años su uso se está …